Alpha Tau Medical (DRTSW) to join five investor conferences in September

Rhea-AI Filing Summary

Alpha Tau Medical Ltd. furnished a Form 6-K to provide investors with a press release dated August 27, 2025. The release, attached as Exhibit 99.1, announces that the company will participate in five investor conferences scheduled for September.

The furnished information, including the press release, is not deemed filed for liability purposes under the U.S. Exchange Act and is not automatically incorporated by reference into other U.S. securities filings unless specifically referenced there.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

Accepted by SEC EDGAR 08/27/2025 - 08:32 AM Learn about SEC filing dates

FAQ

What did Alpha Tau Medical Ltd. (DRTSW) disclose in its August 2025 Form 6-K?

Alpha Tau Medical Ltd. furnished a Form 6-K noting it issued a press release on August 27, 2025. The release announces the company’s participation in five investor conferences in September and is attached as Exhibit 99.1 for investors seeking additional detail.

How many investor conferences will Alpha Tau Medical (DRTSW) attend in September 2025?

Alpha Tau Medical plans to participate in five investor conferences during September 2025. This information comes from a press release dated August 27, 2025, which the company furnished to investors as Exhibit 99.1 to its Form 6-K report with the U.S. securities regulator.

Is Alpha Tau Medical’s August 27, 2025 press release considered filed with the SEC?

The August 27, 2025 press release is furnished, not filed, with the SEC. This means it is not subject to Section 18 liability under the Exchange Act and is only incorporated into other filings if specifically referenced there by Alpha Tau Medical Ltd.

Where can investors find details on Alpha Tau Medical’s September investor conferences?

Investors can find details in the press release titled “Alpha Tau to Participate in Five September Investor Conferences.” This release is attached as Exhibit 99.1 to Alpha Tau Medical’s Form 6-K dated August 27, 2025, and provides the underlying conference information.

Does the Alpha Tau Medical (DRTSW) Form 6-K include financial results or earnings data?

The Form 6-K describes the furnishing of a press release about investor conferences and does not present earnings data. Its focus is on Alpha Tau Medical’s planned participation in five September investor conferences rather than on financial results or operational performance metrics.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO SECTION 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025

Commission File Number: 001-41316

Alpha Tau Medical Ltd.

(Exact Name of Registrant as Specified in Its Charter)

Kiryat HaMada St. 5

Jerusalem, Israel 9777605

+972 (3) 577-4115

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒           Form 40-F  ☐

CONTENTS

On August 27, 2025, Alpha Tau Medical Ltd. (the “Company”) issued a press release titled “Alpha Tau to Participate in Five September Investor Conferences.” A copy of this press release is attached to this Form 6-K as Exhibit 99.1.

The information in this Report on Form 6-K, including in Exhibit 99.1 attached hereto is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise set forth herein or as shall be expressly set forth by specific reference in such a filing.

1

EXHIBIT INDEX

Exhibit No.		Description
99.1		Press release dated August 27, 2025.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Alpha Tau Medical Ltd.
Date: August 27, 2025	By:	/s/ Uzi Sofer
		Uzi Sofer
		Chief Executive Officer

3